ASLAN Pharmaceuticals (ASLN) Short Interest Ratio & Short Volume $0.60 0.00 (0.00%) As of 05/9/2025 Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsOptions ChainSEC FilingsTrendsBuy This Stock ASLAN Pharmaceuticals Short Interest DataASLAN Pharmaceuticals (ASLN) has a short interest of 38,300 shares, representing 1.40% of the float (the number of shares available for trading by the public). This marks a -85.81% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 122,322 shares to cover all short positions.Current Short Interest38,300 sharesPrevious Short Interest269,900 sharesChange Vs. Previous Month-85.81%Dollar Volume Sold Short$91,920.00Short Interest Ratio0.7 Days to CoverLast Record DateJune 30, 2024Outstanding Shares2,044,000 sharesFloat Size2,730,000 sharesShort Percent of Float1.40%Today's Trading Volume0 sharesAverage Trading Volume122,322 sharesToday's Volume Vs. Average0% Short Selling ASLAN Pharmaceuticals? Sign up to receive the latest short interest report for ASLAN Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartASLN Short Interest Over TimeASLN Days to Cover Over TimeASLN Percentage of Float Shorted Over Time ASLAN Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202438,300 shares $91,920.00 -85.8%1.4%0.7 $2.40 6/15/2024269,900 shares $110,659.00 -9.3%1.2%0.6 $0.41 5/31/2024297,400 shares $127,495.08 -1.6%1.4%0.3 $0.43 5/15/2024302,200 shares $120,880.00 -56.9%1.4%0.2 $0.40 4/30/2024700,400 shares $322,184.00 +179.9%4.1%0.6 $0.46 4/15/2024250,200 shares $126,426.06 +114.2%1.5%0.2 $0.51 3/31/2024116,800 shares $71,855.36 -59.8%0.7%0.1 $0.62 3/15/2024290,500 shares $188,825.00 +1,405.2%1.8%0.3 $0.65 2/29/202419,300 shares $16,984.00 -38.3%0.1%0 $0.88 2/15/202431,300 shares $17,625.03 -46.7%0.2%0.1 $0.56 Get the Latest News and Ratings for ASLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ASLAN Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/202458,700 shares $40,062.75 +9.3%0.4%0.3 $0.68 1/15/202453,700 shares $50,773.35 -24.4%0.3%0.3 $0.95 12/31/202371,000 shares $37,069.10 +203.4%0.4%0.5 $0.52 12/15/202323,400 shares $13,525.20 -31.4%0.2%0.2 $0.58 11/30/202334,100 shares $23,535.82 -19.2%0.2%0.6 $0.69 11/15/202342,200 shares $43,044.00 +20.9%0.3%1.3 $1.02 10/31/202334,900 shares $38,390.00 +3.6%0.3%1.4 $1.10 10/15/202333,700 shares $43,136.00 -32.2%0.2%1.3 $1.28 9/30/202349,700 shares $93,436.00 -78.3%0.4%1.4 $1.88 9/15/2023228,600 shares $448,056.00 -6.5%1.7%2.2 $1.96 8/31/2023244,500 shares $519,562.50 -20.9%1.8%2 $2.13 8/15/2023308,900 shares $651,779.00 -6.9%2.2%2.2 $2.11 7/31/2023331,600 shares $782,576.00 0.0%2.6%2.2 $2.36 7/15/2023331,700 shares $932,077.00 +203.8%2.6%2.2 $2.81 6/30/2023109,200 shares $398,580.00 +105.3%1.0%0.8 $3.65 6/15/202353,200 shares $212,268.00 +25.2%0.5%0.7 $3.99 5/31/202342,500 shares $170,000.00 -91.2%0.4%0.8 $4.00 5/15/2023483,800 shares $2.10 million +16.5%4.2%9.6 $4.35 4/30/2023415,400 shares $1.72 million +1.7%3.1%10.4 $4.15 4/15/2023408,300 shares $1.44 million +3.7%3.0%10.4 $3.53 3/31/2023393,700 shares $1.13 million +1.0%2.9%10.8 $2.88 3/15/2023389,900 shares $1.25 million -79.9%2.9%9.5 $3.20 2/28/20231,940,000 shares $1.46 million +1.0%2.9%10.9 $0.76 2/15/20231,920,000 shares $1.52 million -1.0%2.9%10.9 $0.79 1/31/20231,940,000 shares $1.33 million +3.2%2.9%11.2 $0.69 1/15/20231,880,000 shares $1.20 million No Change2.8%8.1 $0.64 12/30/20221,880,000 shares $676,800.00 -0.5%2.8%8.5 $0.36 12/15/20221,890,000 shares $869,400.00 No Change2.8%9.9 $0.46 11/30/20221,890,000 shares $1.04 million -3.6%2.8%9.9 $0.55 11/15/20221,960,000 shares $975,296.00 -1.0%2.9%9.5 $0.50Elon just did WHAT!? (Ad)As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.Click here to see how to claim your stake before they launch to avoid missing out. 10/31/20221,980,000 shares $799,920.00 +3.7%3.0%8.6 $0.40 10/15/20221,910,000 shares $957,101.00 -3.1%2.9%12 $0.50 9/30/20221,970,000 shares $1.18 million +2.1%2.9%12.7 $0.60 9/15/20221,930,000 shares $1.45 million +4.9%2.9%11.1 $0.75 8/31/20221,840,000 shares $1.14 million +0.6%2.8%8.4 $0.62 8/15/20221,830,000 shares $1.66 million +1.1%2.7%7.2 $0.90 7/31/20221,810,000 shares $838,211.00 -1.1%2.8%7.2 $0.46 7/15/20221,830,000 shares $933,300.00 -1.1%2.8%7 $0.51 6/30/20221,850,000 shares $915,750.00 +40.2%2.9%6.9 $0.50 6/15/20221,320,000 shares $508,200.00 +12.8%2.0%5.3 $0.39 5/31/20221,170,000 shares $472,680.00 +244.4%1.8%4.9 $0.40 5/15/2022339,700 shares $157,960.50 +30.0%0.5%1.8 $0.47 4/30/2022261,400 shares $176,654.12 +299.7%0.4%1.6 $0.68 4/15/202265,400 shares $49,115.40 -18.4%0.1%0.4 $0.75 3/31/202280,100 shares $72,065.97 -25.0%0.1%0.5 $0.90 3/15/2022106,800 shares $82,225.32 -21.1%0.2%0.5 $0.77 2/28/2022135,300 shares $116,358.00 +1.3%0.2%0.6 $0.86 2/15/2022133,600 shares $126,960.08 +26.8%0.2%0.5 $0.95 1/31/2022105,400 shares $100,635.92 +10.8%0.2%0.4 $0.95 1/15/202295,100 shares $102,708.00 +0.7%0.2%0.3 $1.08 12/31/202194,400 shares $105,728.00 -46.1%0.2%0.2 $1.12 12/15/2021175,100 shares $220,626.00 +78.5%0.3%0.2 $1.26 11/30/202198,100 shares $141,264.00 -37.1%0.2%0.1 $1.44 11/15/2021155,900 shares $260,353.00 -56.6%0.3%0.1 $1.67 10/29/2021358,900 shares $602,952.00 -24.4%0.6%0.3 $1.68 10/15/2021474,800 shares $740,688.00 -59.8%0.7%0.4 $1.56 9/30/20211,180,000 shares $2.10 million -15.1%1.8%1.1 $1.78 9/15/20211,390,000 shares $4.20 million -3.5%2.2%1.4 $3.02 8/31/20211,440,000 shares $3.84 million -20.0%2.2%1.5 $2.67 8/13/20211,800,000 shares $5.09 million +2.9%5.1%2 $2.83 7/30/20211,750,000 shares $4.85 million +6.1%5.0%2 $2.77 7/15/20211,650,000 shares $4.62 million +8.6%4.5%1.9 $2.80 6/30/20211,520,000 shares $5.02 million -4.4%4.2%1.8 $3.30 6/15/20211,590,000 shares $5.58 million +4.6%4.4%3.3 $3.51 5/28/20211,520,000 shares $4.51 million -11.6%4.2%2.1 $2.97 5/14/20211,720,000 shares $4.30 million -3.4%N/A0.8 $2.50 4/30/20211,780,000 shares $5.73 million No ChangeN/A0.8 $3.22 4/15/20211,780,000 shares $5.61 million +34.9%N/A0.8 $3.15 3/31/20211,320,000 shares $4.29 million +10.0%N/A0.6 $3.25 3/15/20211,200,000 shares $4.92 million +13,693.1%N/A0.6 $4.10 2/26/20218,700 shares $38,802.00 -47.6%N/A0 $4.46 2/12/202116,600 shares $58,930.00 +29.7%N/A0 $3.55 1/29/202112,800 shares $28,800.00 +276.5%N/A0 $2.25 1/15/20213,400 shares $6,460.00 -74.2%N/A0 $1.90 12/31/202013,200 shares $24,288.00 -53.2%N/A0 $1.84 12/15/202028,200 shares $58,092.00 +16.1%N/A0.1 $2.06 11/30/202024,300 shares $45,684.00 -88.1%N/A0.1 $1.88 11/15/2020204,800 shares $327,680.00 -2.0%N/A0.8 $1.60 10/30/2020209,000 shares $342,760.00 +1.0%N/A0.9 $1.64 10/15/2020207,000 shares $398,475.00 -13.7%N/A0.9 $1.93Elon just did WHAT!? (Ad)As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.Click here to see how to claim your stake before they launch to avoid missing out. 9/30/2020239,900 shares $455,810.00 +10.3%N/A3.1 $1.90 9/15/2020217,600 shares $328,576.00 +53.0%N/A2.4 $1.51 8/31/2020142,200 shares $214,722.00 +6.4%N/A1.5 $1.51 8/14/2020133,700 shares $215,257.00 +23.7%N/A1.4 $1.61 7/31/2020108,100 shares $163,231.00 +640.4%N/A0.9 $1.51 7/15/202014,600 shares $25,550.00 -47.9%N/A0.1 $1.75 6/30/202028,000 shares $56,000.00 -38.7%N/A0.2 $2.00 6/15/202045,700 shares $88,201.00 +297.4%N/A0.3 $1.93 5/29/202011,500 shares $20,227.35 -35.4%N/A0.1 $1.76 5/15/202017,800 shares $27,590.00 -19.8%N/A0.1 $1.55 ASLN Short Interest - Frequently Asked Questions What is ASLAN Pharmaceuticals' current short interest? Short interest is the volume of ASLAN Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 38,300 shares of ASLN short. 1.40% of ASLAN Pharmaceuticals' shares are currently sold short. Learn More on ASLAN Pharmaceuticals' current short interest. What is a good short interest ratio for ASLAN Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ASLN shares currently have a short interest ratio of 1.0. Learn More on ASLAN Pharmaceuticals's short interest ratio. What is a good short interest percentage for ASLAN Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.40% of ASLAN Pharmaceuticals' floating shares are currently sold short. Is ASLAN Pharmaceuticals' short interest increasing or decreasing? ASLAN Pharmaceuticals saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 38,300 shares, a drop of 85.8% from the previous total of 269,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ASLAN Pharmaceuticals' float size? ASLAN Pharmaceuticals currently has issued a total of 2,044,000 shares. Some of ASLAN Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ASLAN Pharmaceuticals currently has a public float of 2,730,000 shares. How does ASLAN Pharmaceuticals' short interest compare to its competitors? 1.40% of ASLAN Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ASLAN Pharmaceuticals: Soligenix, Inc. (5.63%), Evoke Pharma, Inc. (1.84%), Aptorum Group Limited (1.15%), Adial Pharmaceuticals, Inc. (3.36%), Onconetix, Inc. (3.45%), Alzamend Neuro, Inc. (3.54%), Clearmind Medicine Inc. (3.95%), CERo Therapeutics Holdings, Inc. (8.12%), Ensysce Biosciences, Inc. (11.21%), Alaunos Therapeutics, Inc. (6.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks. What does it mean to sell short ASLAN Pharmaceuticals stock? Short selling ASLN is an investing strategy that aims to generate trading profit from ASLAN Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ASLAN Pharmaceuticals? A short squeeze for ASLAN Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ASLN, which in turn drives the price of the stock up even further. How often is ASLAN Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ASLN, twice per month. The most recent reporting period available is June, 30 2024. More Short Interest Resources from MarketBeat Related Companies Soligenix Short Interest Evoke Pharma Short Interest Aptorum Group Short Interest Adial Pharmaceuticals Short Interest Onconetix Short Interest Alzamend Neuro Short Interest Clearmind Medicine Short Interest CERo Therapeutics Short Interest Ensysce Biosciences Short Interest Alaunos Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ASLN) was last updated on 5/10/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponWall Street is nervous. Billionaires are shifting assets. And everyday investors? Most are completely unprepa...American Alternative | Sponsored[FREE GIFT] New AI for retail tradersTradeAlgo has found a “backdoor way” for retail traders to profit from the AI arms race by developing its grou...TradeAlgo | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredOne Stock Gold Blueprint to Survive the Market ChaosOne Stock Gold Blueprint to Survive the Market Chaos Markets are volatile, uncertainty is everywhere, and A...InvestorPlace | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew breed of trader (Wall Street hates us?)Wall Street big wigs and old-money bankers can’t touch this 1 type of stock. And that opens the door for tr...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASLAN Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share ASLAN Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
